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In healthy individuals, exercise induces an initial net muscle protein breakdown (22) , which increases intramuscular concentration of amino acids. Subsequently, amino acids activate the protein synthesis signaling cascade, resulting in a positive net muscle protein balance after exercise (10, 22) . Protein supplementation ingested immediately after both resistance and endurance exercise enhances this exercise-induced muscle protein synthesis (6, 7, 16, 27) . Glucose stimulates insulin secretion, and the anabolic effect of insulin, in combination with essential amino acids, increases muscle protein synthesis more than by providing essential amino acids alone (4) .
We investigated exercise-induced muscle protein balance before, during, and 3 h after one-legged knee-extensor exercise, with and without postexercise protein-carbohydrate supplementation in patients with FSHD, DM1, BMD, and LGMD2I, and healthy subjects 1) to assess whether exerciseinduced muscle protein breakdown, synthesis, and fractional synthetic rate (FSR) is enhanced in diseased muscle and 2) to investigate the effect of postexercise protein-carbohydrate supplementation on these parameters.
MATERIALS AND METHODS

Subjects.
Patients were recruited from our Neuromuscular Clinic, Rigshospitalet, Denmark. We included 7 women and 10 men, aged 33 Ϯ 11 years (18 -52), with a body mass index (BMI) of 22 Ϯ 3 kg/m 2 (16 -26) , and with genetically verified muscle diseases: seven DM1 patients carrying 100 -300 CTG-repeats in the DMPK gene, two BMD patients carrying an exon 26 deletion and an in-frame deletion of exons 45-48 in the dystrophin gene, two LGMD2I patients homozygous for the L276I mutation in the FKRP gene, and six FSHD patients carrying deletions in subtelomere of chromosome 4q35 with 4 -10 remaining D4Z4 units. Exclusion criteria were 1) other diseases compromising motor function, 2) serious heart or lung conditions, 3) pregnancy and breastfeeding, and 4) inability to perform 40 min of moderate one-legged kicking exercise (severe muscle weakness). All patients were ambulatory. One LGMD2I patient used a walking stick for community ambulation.
Eight healthy subjects matched for sex, age, BMI, and physical activity level were included [three women and five men, aged 33 Ϯ 13 (19 -54) yr, with a BMI of 23 Ϯ 3 (19 -27) kg/m 2 ]. Four of the patients (two DM1, one LGMD, and one BMD) and two of the healthy subjects did not agree to perform a second trial because of the invasive methodology.
Ethics. The study was approved by the Ethical Committees of Copenhagen, Denmark [(KF) 01 320211] and was performed in accordance with the Declaration of Helsinki. Subjects were informed about the risks and discomfort involved before they provided written consent to participate.
Preexperimental testing. To investigate muscle protein balance, we chose a one-leg model, in which exercise and sampling were isolated to one leg. A maximal incremental exercise test was performed, by increasing workload every other minute until exhaustion. The test was used to determine a workload that corresponded to 70% of maximal leg oxygen uptake (V O2peak). Aerobic exercise was performed on a one-leg kicking cycle (Fig. 1A) , a special ergometer bike constructed to investigate aspects during aerobic exercise (1) . Subjects exercised with a cadence of 60 kicks/min. Gas exchanges (V O2 and V CO2) were measured with a gas and airflow analyzer (Quark b 2 , Cosmed, Italy) during the tests. Every other minute, the level of perceived exertion was scored on a Borg scale (5, 9). Heart rate was monitored continuously (S&W Medico technique A/S, Albertslund, Denmark). To practice the one-leg kicking technique, and to ensure that subjects could perform the expected exercise program, a 40-min submaximal (70% V O2peak) test was performed.
Experimental design. After the preexperimental examination, the subjects came to the laboratory on two other experimental days, separated by at least a month. The first day (non-sup) and the second day (PC-sup) were identical, except that subjects consumed a proteincarbohydrate supplement (PC-sup) on the second test day (Fig. 1) . Three days before each experiment, subjects were instructed to follow a standardized carbohydrate-rich diet and to refrain from ingesting food items containing corn. All experiments were performed in the morning after an overnight fast. Subjects were served a standardized breakfast containing a whole grain roll with jam ϳ3 h before data sampling. Water ad libitum was allowed during both the fasting and the trial periods.
For stable isotope infusion, a catheter (20GA, 26-inch BD Venflon Pro) was placed in the cubital fossa vein. For blood sampling, catheters (Pediatric Jugular Catheterization, 20GA, 12-cm, 0.02-inch diameter, spring wire guide) were inserted in the right femoral artery and vein. Seldinger technique was used, under local anesthesia (lidocaine: 20 mg/ml) to place the catheters 1-2 cm proximal to the bifurcation and distal to the inguinal ligament. All catheters were kept patent by infusion (0.9% saline, containing heparin).
A Blood samples were obtained before, during, and after exercise, as shown in Fig. 1 . Simultaneously with blood sampling, blood flow was determined just above the bifurcation of the femoral artery by ultrasound Doppler technique (Vivid I, General Electrics) (23) .
Muscle biopsies were taken from the right vastus lateralis muscle (5-mm Bergstrøm needle) before tracer infusion, and 3 h postexercise (Fig. 1) . The biopsies were performed under local anesthesia (2 ml lidocaine: 20 mg/ml; norepinephrine: 5 g/ml). The tissue was immediately washed free of visible blood, frozen in liquid nitrogen, and stored at Ϫ80°C until analysis.
On the second experimental day, subjects consumed a commercially available oral protein-carbohydrate drink within 5 min after the 40-min kicking exercise. The drink consisted of 40 g 50/50 ProMax powder dissolved in 0.4 liter skim milk, thus containing 32.8 g protein, 36.6 g carbohydrate, 1.4 g fat, and 1238 kJ in total.
Blood sample analyses. All blood samples were mixed with EDTA (ethylene-diamine-tetraacetic acid) (0.1 ml 0.33 M EDTA/ml blood), immediately centrifuged (5 min, at 4°C, with 3,000 rcf, centrifuge 5702; Eppendorf), and plasma samples were stored at Ϫ80°C until analyzed for lactate and glucose (Yellow Springs Instruments 2300 STAT PLUS, Yellow Springs, OH), insulin (Insulin ELISA 96T; Dako, Glostrup, Denmark), catecholamines (CAT RIA, IBL International, Hamburg, Germany), and free fatty acid (FFA) (96-well serum/plasma fatty acid kit 1,000 point kit, cat. no. SFA-10; Zenbio, Research Triangle Park, NC).
Concentration and enrichment of phenylalanine were analyzed in arterial and venous plasma, as well as in the infusate. To calculate the concentration of total phenylalanine, we analyzed the enrichment of an internal standard with a known concentration of labeled phenylalanine. Internal standards (100 l) were added to the samples (250 l) and prepared with 500 l 50% acetic acid during the cation exchange under column chromatography (AG 50Wx8; Bio-Rad, Hempel Hempstead, UK). The samples were eluted with 2 M NH4OH (ammonium hydroxide), and dried overnight. To prepare derivates, we added 50 l of acetonitrile and 50 l of N-methyl-N-(tert-butyldimethylsilyl)-trifluoroacetamide and heated the samples at 70°C for 1 h. The enrichment of plasma samples and internal standard was measured by GC-MS (Finnigan Automass II, Paris, France).
Muscle sample analyses. Muscle biopsies were cleaned under a stereomicroscope for blood and visible connective tissue. To measure the dry weight of the muscle tissue, biopsies were freeze-dried under vacuum for 4 days. One hundred microliters of a 10ϫ diluted internal standard was added. The samples were homogenized with 500 l of Fig. 1 . Flowchart of the experiments. A: exercise was performed on a specially constructed one-leg kicking ergometer cycle to isolate the movement to the quadriceps muscle only. The right leg was fixed to the chair with straps, and the right foot was fixed in a boot connected to the ergometer cycle (Monark 824E Ergometer). The one-leg kicking ergometer cycle has an "own-load," and additional loads could be added to increase the workload at the back. A 100-g load added corresponded to increasing the load on the bike by 12 W. B: exercise was performed on the one-leg kicking ergometer cycle on two occasions. Catheters were inserted in the right femoral artery and vein. Exercise was performed at 70% of maximal oxygen uptake with a cadence of 60 kicks/min. We used leucine and phenylalanine to trace muscle protein turnover. A protein-carbohydrate drink (PC-sup) or no supplement (non-sup) was given after exercise. sulfosalicylic acid, centrifuged, and divided into pellet and supernatant; this process was repeated three times. The supernatant was analyzed with the same method as described for the plasma. The pellet was washed with ethanol and dried with nitrogen. The protein in the pellet was hydrolyzed with 6 M HCl (hydrogen chloride), heated, and dried before the cation exchanging and derivation with N-acetyl n-propyl ester (NAP) was undertaken. Then the NAP-leucine derivates were determined by GC-combustion-isotope ratio MS (GC-C-IRMS; Finnigan Deltaϩ, Bremen, Germany).
Western blot analysis was performed as described before (13) . In brief, muscle sections were homogenized, and equal amounts of extracted muscle proteins were separated and transferred to PVDF membranes. Membranes were blocked, before incubation overnight with the following primary antibodies: PI3K Immunoreactive bands were detected (SuperSignal West Dura kit; Thermo Scientific, Waltham, MA) and were quantified (Gbox XT16 darkroom); then, the intensities of immunoreactive bands were measured (16-bit digital photos, GeneTools software; Syngene, Cambridge, UK).
Calculations. Different amino acid pools are involved in muscle protein metabolism. Metabolites were assessed in two plasma pools, the arterial and the venous pools, and two muscle pools, the intracellular pool (the supernatant of the homogenized muscle biopsy), and the protein pool (pellet of the homogenized muscle biopsy), as described by Robert R. Wolfe (28) . In these pools, amino acids flow between the arterial and venous pools through the intracellular pool, and from here, to and from the muscle-protein pool. Concentrations were calculated: Cs ϭ [(Vis·Cis)/(Vs·Eis)]. Whole body protein balance was calculated from the arterial pool: Whole body R a ϭ [(T/Ea)]. Leg protein net balance (NB) was calculated as the difference between the arterial (a) and venous (v) pools: NB ϭ (Ca Ϫ Cv)·LBF. The leg phenylalanine uptake, a measure for leg muscle protein synthesis, was estimated by the rate of labeled phenylalanine disappearance (Rd) from the arterial pool into the leg;
The leg phenylalanine release or rate of appearance (Ra) into the circulation, a measure for leg muscle protein breakdown, was assessed from the net balance and rate of phenylalanine disappearance: R a ϭ Rd Ϫ NB. The mixed-muscle FSR was calculated from the measured enrichment of leucine in the two muscle pools: the intracellular pool and the protein pool from muscle biopsies: FSR ϭ [EMuscle tissue (pellet) 100%]/(Eintracellular muscle water 6 h) (28) In these equations, V is volume, T is phenylalanine infusion rate, LBF is leg blood flow, s is sample, and is means internal standard.
Statistical analyses. Descriptive values are presented as means Ϯ SD (range). Results are presented as means Ϯ SE. We used a paired Student's t-test (two-tailed test) to compare differences between rest (mean of three blood samples) and exercise (mean of four samples) and recovery (mean of six blood samples) between the first and second muscle biopsy and non-sup and PC-sup. An unpaired Students t-test (two-tailed testing) was used to compare differences between patients and healthy controls in non-sup. A P value less than 0.05 was considered significant.
Patients with four different types of muscular dystrophies were included in the study. The same tendencies were found in results from all subgroups. Thus, all four groups were pooled to increase the statistical power of the analysis. Since DM1, unlike the other muscular dystrophies studied, is a multisystem disorder, we made a subgroup analysis of phenylalanine kinetics in this group (Table 1) .
RESULTS
Metabolites
, hormones, and cardiovascular responses. During the 40-min one-legged kicking exercise, heart rate, perceived exertion, blood flow, plasma lactate, and catecholamines were comparable between non-sup and PC-sup. They increased to the same level in both patients and controls ( Table  2 ), indicating that patients and healthy controls performed exercise at the same relative work intensity. Plasma concentrations of leucine, phenylalanine, glucose, and insulin increased, and FFA levels decreased 30 min after supplementation in all subjects (Fig. 2) . Without any outliers, insulin increased significantly together with blood glucose after protein supplementation, indicating a normal insulin secretion. Blood glucose returned to normal (Ͻ6 mmol/l) within an hour after supplementation in all subjects except for two patients [LGMD (7.1 mmol/l) and FSHD (6.4 mmol/l)], indicating a Values are mean (mol/min). The DM1 (dystrophia myotonica type 1 patients; n ϭ 5) group was compared with healthy control subjects (n ϭ 6) for all patients and controls (see Fig. 3 ). *Significant difference (P Ͻ 0.003) between the nonsupplementation trial (nonsup) and the protein-carbohydrate supplementation trial (PC-sup). normal glucose-insulin response. Insulin increased similarly in all groups with no single patient representing an outlier, indicating that none of the patients were insulin-resistant (range: 207-468 pmol/l).
Muscle phenylalanine balance. Whole body phenyalalanine rate of appearance was lower in patients than in controls at rest (87 Ϯ 2 vs. 100 Ϯ 6 mol/min), during exercise (92 Ϯ 2 vs. 104 Ϯ 4 mol/min), and in the recovery period (81 Ϯ 2 vs. 94 Ϯ 3 mol/min) (P ϭ 0.01).
At rest, muscle phenyalalanine net balance across the leg was similar among patients and controls, although both the rates of muscle phenyalalanine uptake and release were lower in patients (P ϭ 0.005). During exercise, the phenylalanine net balance and uptake were unchanged, but the phenylalanine release was increased in both patients (P ϭ 0.01) and healthy controls (P ϭ 0.006) (Fig. 3, top) .
In the 3-h non-sup recovery period, the phenylalanine release remained increased in patients and caused a significantly exercise-induced net loss of phenylalanine (P ϭ 0.01) (Fig. 3,  middle) .
Postexercise PC-sup induced an increase in leg phenylalanine net uptake in patients (P ϭ 0.001) and controls (P ϭ 0.01). In healthy controls, phenylalanine leg uptake increased (P ϭ 0.004), indicating protein synthesis. In patients, the phenylalanine leg uptake was similar at rest and postexercise, indicating that protein synthesis was unaffected. However, the significant increase in leg phenylalanine release seen in the non-sup recovery period was absent after PC-sup (P ϭ 0.003), indicating that PC-sup reduced muscle protein breakdown in the patients with muscular dystrophies (Fig. 3, bottom) .
Muscle protein synthesis rate. From muscle biopsies, we measured the FSRs to compare the effect of PC-sup. The mixed-muscle FSR was similar in patients and healthy individuals without supplementation and increased with PC-sup (patients: P ϭ 0.03, n ϭ 9; controls: P ϭ 0.21, n ϭ 3) (Fig. 4) .
Activation of muscle protein synthesis. Phosphorylation of proteins involved in the signaling cascade of muscle protein synthesis was analyzed by Western blot analysis (Fig. 5) . Because of a lack of muscle specimens, we were unable to perform Western blots for all proteins of the cascade to make paired analysis in all other subjects than DM1. The activation appeared to be at different stages of the cascade; therefore, a qualitative presentation of the data is provided in Table 3 , where exercise activated the muscle protein synthesis cascade in six out of seven patients with DM1.
DISCUSSION
Patients with muscular dystrophies suffer from an accelerated loss of muscle proteins, resulting in progressive muscle wasting throughout life. Aerobic exercise training has been shown to effectively improve fitness, and in some cases, also muscle strength in these conditions (25) . In healthy individuals, exercise induces muscle protein anabolism, which can be enhanced by postexercise protein supplementation (6, 7, 16) .
In the present study, we found that patients with muscular dystrophies following exercise have an accelerated degradation of muscle proteins, but a similar net muscle protein balance compared with healthy controls. However, when patients in recovery from exercise were provided protein-carbohydrate supplementation, the net muscle protein breakdown was abol- Fig. 2 . Arterial concentrations of phenylalanine, leucine, glucose, insulin, and FFA in patients with muscular dystrophies and healthy matched subjects. In one trial, the participants did not consume anything (non-sup), and in the other trial, they consumed a protein-carbohydrate-containing drink after exercise (PC-sup). Exercise lasted 40 min (from 0 to 40). FFA, free fatty acids. All concentrations changed significantly after PC-sup in patients and controls (mean of the six postexercise samples). Error bars show means Ϯ SE.
ished, albeit less than in healthy controls, via a reduced muscle breakdown and increase in muscle FSR.
Our findings of an anabolic effect of postexercise PC-sup in muscular dystrophies are encouraging and suggest that a longterm aerobic training program with postexercise protein-carbohydrate ingestion should be undertaken to determine whether this anabolic effect translates into durable improvements in muscle function.
Muscle protein balance. In the recovery period we found that a single bout of exercise significantly increased postexercise muscle protein breakdown in patients with DM1, FSHD, BMD, and LGMD2I during the first 3 h of recovery, which contrasted findings in healthy subjects, in whom there was a positive protein balance postexercise as earlier described (8, 16) . This seems to support the old notion that patients with muscular dystrophies should refrain from exercise training, because it can potentially damage muscle fibers and accelerate the disease process. This notion was built on studies in mdx mice performing eccentric contraction (3, 21, 24) , which is known to cause muscle injury, also in healthy humans. However, the time frame of 3 h in the current study does not explain what happens later on with muscle protein metabolism. Training without protein supplementation in various muscular dystrophies investigated in the current study, have consistently shown improvements in fitness without evidence of muscle injury (2, 18, 19, 25, 26) , which suggests that in the long run, protein balance with training is positive. Furthermore, muscle strength was improved in BMD patients (25) , muscle fiber area increased in DM1 patients (19) , and capillary density increased in LGMD2I patients (26) after aerobic training, which also indicates a positive net muscle protein balance. In accordance with this, the present study showed that FSR was similar between patients and healthy controls and that the protein synthesis signaling cascade was activated after exercise in patients in whom it could be assessed (DM1). On the basis of these observations, we advise our patients to perform regular endurance training to improve endurance and muscle performance, as well as to prevent life-style disorders.
The protein-synthesis signaling cascade is a "flooding" process that has in growth factor-treated normal mice a small Fig. 3 . Leg phenylalanine metabolism. Net phenylalanine uptake represents net muscle protein synthesis (in case of a negative number, it signifies a net muscle protein loss). Unidirectional phenylalanine uptake represents muscle protein synthesis, and release represents muscle protein breakdown, assuming that the muscle free phenylalanine pool is unchanged. Rest is the preexercise period, exercise covers a 40-min exercise period, and recovery covers a 3-h period following exercise. *Significant differences between non-sup and PC-sup in same period and group (P Ͻ 0.01). #Significant differences from rest in the same group (P Ͻ 0.04). Error bars show means Ϯ SE. Fig. 4 . Muscle protein synthesis rate. Muscle protein synthesis rate was calculated from the amount of leucine incorporated into the muscle tissue over 6 h. *Significant difference between the baseline biopsy and the end of recovery biopsy (P ϭ 0.03). Patients: n ϭ 9. Control: n ϭ 3. Error bars show means Ϯ SE.
temporal window of phosphorylated proteins (14) , which is essential for measuring the cascade. No similar studies have been done in humans; thus, the best time to measure each component of the signaling cascade is unknown. In the current study, exercise induced an active protein synthesis signaling cascade in most of patients with DM1, but the cascade occurred in different phases in the subjects.
Whole body metabolism and the leg muscle protein balance at rest and during exercise were qualitatively similar between patients and healthy controls, but the absolute rates were lower in patients. Since leg muscle mass is considerably lower in patients vs. healthy controls, the lower phenylalanine release and uptake in the patients at rest and during exercise do not necessarily imply a lower muscle protein breakdown and synthesis. The influence of muscle mass on the absolute levels of protein turnover could not be ascertained in our study, since the participants' muscle mass was not measured.
Postexercise protein-carbohydrate supplementation. The effect of different protein and amino acid supplements in combination with resistance exercise training has been investigated thoroughly in healthy subjects. In contrast, knowledge about the effect of combined protein supplementation and endurance training is much less investigated. In our study, PC-sup caused net muscle anabolism in healthy controls, as expected, whereas in patients, PC-sup abolished net catabolism caused by a reduced muscle protein breakdown and increased FSR in the studied 3-h recovery period. These encouraging findings of an anabolic effect of oral supplementation after endurance exercise are supported by a study using a comparable protocol, in which Murphy and Miller found an increased whole body protein turnover in elderly, healthy subjects (16) . Furthermore, protein supplements after endurance exercise reduce muscle injuries and improve retest results after a recovery period in healthy individuals (8) . A higher resynthesis of muscle glycogen and a greater protein synthesis signaling cascade activation were demonstrated after protein supplementation compared with both an isocaloric carbohydrate and a placebo supplementation (8) .
Whether the positive effect of protein-carbohydrate supplementation after an acute exercise bout on muscle protein balance, as shown in our study, has potential long-term effects is unknown. In healthy, young men, long-term protein supplementation increased the maximal oxygen uptake more than supplementation with carbohydrate or placebo alone (7) . Similar results were found in older men (17) and in patients with chronic obstructive pulmonary disease (15) , which is encouraging for conducting long-term trials in patients with muscular dystrophies.
In the present study, we focused on the effect of aerobic exercise, since it is known to have many beneficial health effects and is safe in muscular dystrophies. The beneficial effect on muscle protein metabolism after supplementation in both patients and in healthy controls in the present study Fig. 5 . Muscle protein synthesis signaling pathway. A: proteins involved in the cascade of protein synthesis in muscle cells, which were analyzed in our study. The bold arrows indicate whether the molecule increases or decreases when the protein synthesis pathway is activated. B: Western blot analysis of activated enzymes of the protein synthesissignaling cascade when no supplements are provided (non-sup) and when a protein-carbohydrate supplementation (PC-sup) is provided in a representative subject (DM1 patient). Rest represents the first biopsy, and recovery (3 h) represents the second biopsy (see Fig. 1 ). ␣-Tubulin was used as a load control to normalize bands. Vertical lines signify discontinuous lanes on the same blot. Nonsup trial PI3K (p55)  153  63  75  1337  41  235  297  PDK1  80  15  349  4  148  14  129  AKT (S473)  44  16  27  76  25  46  87  70S6K  503  87  242  5  22  67  1380  S6  51  15  384  7  115  nd  152  4E-BP1  276  44  153  6  200  55  58  MURF1  90  184  81  49  164  88  84  PC-sup trial  PI3K (p55)  114  78  52  57  35  PDK1  31  114  91  15  6  AKT (S473)  36  16  41  19  83  70S6K  244  315  751  85  1102  S6  43  207  nd  28  85  4E-BP1  112  78  17  62  84  MURF1  92  150  135  113  158 Phosporylation of proteins involved in protein-synthesis signaling-cascade 3-h postexercise, analyzed by Western blotting, expressed as change in pixilation of the band from baseline (100%). An active cascade starts with a dephosphorylation of pPI3K(p55) followed by phosphorylation af PDK1, AKT, 70S6K, S6, and 4E-BP1, respectively. MURF1 is a protein involved in protein degradation by increased phosphorylation. Nd, not determined; Nonsup, nonsupplementation trial (n ϭ 7); PC-sup, protein-carbohydrate supplementation (n ϭ 5). Two subjects did not perform the PC-sup trial. In the nonsup trial, the cascade is active in participants 1, 3, 5, and 7, with phosphorylation of 70S6K, S6, or E4-BP1. In participants 4 and 6, PI3K is overexpressed, and the rest of the cascade is dephosphorylated together with MURF1; thus, the cascade has been activated and ended, triggered by a negative feedback mechanism. In participant 2, the cascade is inactive. In the PC-sup trial, the cascade is active in participants 1, 2, 3 , and 5, but inactive in participant 4. suggests that the effect of protein supplementation after strength training should also be considered in muscular dystrophies because of its known anabolic effects in healthy individuals. However, the safety of strength training alone has not been properly investigated in patients with muscular dystrophies.
Protein metabolism in patients with muscular dystrophies has been investigated in DM1 patients in the postabsorptive resting state. Some older studies suggest that muscle wasting in patients with DM1 is caused by a defect in the muscle protein synthesis rather than by a defect in accelerated muscle breakdown (11, 12) . In contrast, another study found that muscle wasting is caused by an elevated protein breakdown in DM1 patients, which could be explained by lower levels of plasma IGF-1 and higher levels of TNF-␣ (20) . A direct comparison between these studies and ours is difficult, as we investigated the leg protein balance in relation to exercise and postexercise PC-sup. However, we found an increased muscle breakdown after exercise and a lack of increase in protein synthesis after postexercise supplementation. The anabolic effect of insulin is important for protein synthesis, and insulin resistance can abolish this effect. DM1 is a multisystemic disorder with a high incidence of insulin resistance. In the current study, all DM1 patients had a normal glucose-insulin response, which indicates normal insulin sensitivity.
Investigation of rare diseases is challenging because of difficulties in recruiting large cohorts of patients to reach sufficient power. In the current study, the complicated methodology, need for fasting, invasive procedures, including femoral catheters and muscle biopsies, the need for a 40-min exercise bout on three occasions and a total duration of each experiment of 8 h, further complicated the recruiting process and explains why some subjects dropped out of the study. However, such complicated techniques are necessary to provide proof-of-concept inputs to the understanding of muscle protein metabolism during and after exercise, as well as the effect of protein supplementation after exercise in muscular dystrophies. The present study is the first of its kind to do this.
A distinction among the periods of rest, exercise, and recovery would define FSR of muscle proteins in each period better. However, to answer this question, two more muscle biopsies would have been required from each participant. This was not feasible in this frail group of patients, considering the invasive nature of the study. In our study, we used muscle protein FSR to compare the effect of the supplementation. The only difference in intervention between the two trials from the beginning of the rest period to the end of the recovery period was the postexercise supplement. It must, therefore, be assumed that protein metabolism was similar at rest and during exercise, because the interventions were identical and that any difference detected in the 3-h recovery period was caused by the protein supplementation. Results from blood samples during the periods of rest and exercise in the two trials were not different, which corroborates the assumption that the experimental conditions were identical in these parts of the experiment.
Perspectives and Significance
In conclusion, we found that postexercise protein supplementation abolished the rate of acute net muscle protein breakdown following exercise in mildly to moderately affected patients with the muscular dystrophies BMD, DM1, LGMD2I, and FSHD. Our findings warrant long-term studies on postexercise protein-carbohydrate supplementation to verify the time frame of the acute effect on muscle protein synthesis, breakdown, and signaling. Further studies should explore the differences in patient vs. healthy individuals and whether these effects are sustained over a longer time periods, resulting in gain of muscle mass. Future studies should also determine whether protein-carbohydrate supplementation should be recommended as an add-on to training in muscular dystrophies.
